MedAlliance

Swiss Medical Technology

MedAlliance is a privately-owned medical technology company. It is headquartered in Nyon, Switzerland, with offices in Germany, Singapore, UK and USA. MedAlliance has been dedicated to developing innovative drug-eluting balloons (DEBs) for patients suffering from life-threatening coronary and peripheral arterial disease. Using breakthrough proprietary technology, MedAlliance has found a unique solution to the challenge of controlled and sustained sirolimus release with SELUTION SLR.

SELUTION SLR

SELUTION SLR is the latest generation of drug-eluting balloon technology designed to deliver the same safety and performance as the best-in-class DES technology1 with the added benefit of “leaving nothing behind”. Breakthrough technology combining the proven safety and efficacy of sirolimus with advanced MicroReservoir and Cell Adherent Technology (CAT™) to deliver a sustained therapeutic effect;

  • Controlled and sustained limus release for up to 90 days
  • Offering the broadest range of PTCA and PTA drug-eluting balloon catheters for coronary and peripheral indications.
Visit Website